Osaic Holdings
ACTU

Osaic Holdings’s Actuate Therapeutics ACTU Stock Holding History

Osaic Holdings’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53K Hold
1,000
– – ﹤0.01% 7355
2026
Q1 		$2.74K Hold
1,000
– – ﹤0.01% 6931
2025
Q4 		$6.12K Hold
1,000
– – ﹤0.01% 6588
2025
Q3 		$8.44K Hold
1,000
– – ﹤0.01% 6468
2025
Q2 		$6.11K Buy
+1,000
New +$8.74K ﹤0.01% 6429

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $159M AUM 34.17% 1-Year Est. Return

Osaic Holdings's ACTU Position: Q2 2026 in Review

Osaic Holdings held its Actuate Therapeutics (ACTU) position steady in Q2 2026 at 1,000 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #7355.

Osaic Holdings first reported a position in ACTU in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.44K in Q3 2025. 64 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

  • Osaic Holdings held 1,000 shares of Actuate Therapeutics worth $1.53K as of Q2 2026.
  • Osaic Holdings left its Actuate Therapeutics share count unchanged in Q2 2026.
  • Actuate Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7355 holding.
  • Osaic Holdings first reported a position in Actuate Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Osaic Holdings's Actuate Therapeutics position peaked at $8.44K in Q3 2025.
  • 64 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.